XERIS BIOPHARMA HOLDINGS INC

Ticker: XERS CUSIP: 98422E103 Class: Common Stock

Rosalind Advisors, Inc.'s Holding History (CIK: 0001622627)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 2,111,700 Value ($000) $16,577 Avg Close $7.87 Range $6.47 - $10.08
Q3 2025
Shares 1,795,766 Value ($000) $14,618 Avg Close $6.64 Range $4.52 - $8.35
Q2 2025
Shares 2,155,594 Value ($000) $10,067 Avg Close $4.58 Range $3.81 - $5.50
Q1 2025
Shares 2,495,986 Value ($000) $13,703 Avg Close $4.04 Range $3.14 - $6.07
Q4 2024
Shares 3,104,995 Value ($000) $10,526 Avg Close $3.22 Range $2.69 - $3.87
Q3 2024
Shares 3,104,995 Value ($000) $8,849 Avg Close $2.57 Range $2.03 - $3.04
Q2 2024
Shares 3,120,170 Value ($000) $7,020 Avg Close $2.02 Range $1.69 - $2.51
Q1 2024
Shares 2,820,170 Value ($000) $6,233 Avg Close $2.59 Range $2.00 - $3.26
Q4 2023
Shares 3,543,685 Value ($000) $8,328 Avg Close $1.85 Range $1.46 - $2.44